The influence of type and duration of cardiovascular complications on antioxidative parameter values in type 2 diabetic patients

Journal of Medical Biochemistry

Volumn 26, Issue 1, 2007, Pages 10-16

  Čolak, Emina ^a   Dimitrijević Srećković, Vesna ^a   Dordevic, Predrag B ^a   Stanković, Sanja ^a   Majkić Singh, Nada ^a   Lalić, Katarina ^a   Lalić, Nebojša ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Antioxidant defense; Cardiovascular complications; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 34249332082     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-007-0002-z     Document Type: Article

References (26)

1. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart 2004; 90: 1398-1403.
2. Haffner SM, Lehto S, Ronnema T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
3. Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovascular Diabetology 2002; 1: 1.
4. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1998; 318: 1315-21.
5. Bucala R, Mitchell R, Arnold K, Innerarity T, Vlassara H, Cerami A. Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J Biol Chem 1995; 270: 10828-32.
6. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993; 90: 6434-38.
7. Schmidt AM, Hori O, Chen JX, Li JF, Zhang J, Cao R, et al. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403.
8. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010-14.
9. Vlassara H, Brownlee M, Monogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1998; 240: 1546-8.
10. Kirstein M, Aston C, Hints R, Vlassara H. Receptor-specific induction of insulin-like growth factor 1 in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 1992; 90: 439-46.
11. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest 2004: 34 (12); 785-802.
12. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995; 38: 201-10.
13. Dominguez CC, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998; 21: 1736-42.
14. Chen MS, Hutchinson ML, Pecoraro RE, Lee WY, Labbe RF. Hyperglycaemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 1983; 32: 1078-81.
15. Yue DK, McLennan S, Fisher E, Heffernan S, Capogreco C, Ross GR, et al. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 1989; 38: 257-61.
16. Čolak E, Majkić-Singh N, Stanković S, Srećković-Dimitrijević V, Crossed D signorCrossed d signević PB, Lalić K, et al. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 2005; 37: 613-20.
17. Goldstein S, Michel C, Boors A, Saran M, Czapsky G. A critical re-evaluation of some assay methods for superoxide dismutase activity. Free Radical Biol Med 1988; 4: 295-303.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of glutathione peroxidase. J Lab Clin Med 1967; 70: 158-63.
19. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-12.
20. rd ed. New York: Academic Press 1974, Vol 3, p. 258-65.
21. Čolak E, Majkić-Singh N, Stanković S, Srećković-Dimitrijević V, Crossed D signorCrossed d signević PB, Lalić K, Lalić N. The influence of glucose concentration on antioxidative parameters values in type 2 diabetic patients with cardiovascular complications. Jugoslov Med Biohem 2006; 25 (2) 173-9.
22. Kimura F, Hasegawa G, Obayashi H, Adachi T, Hara H, Ohta M et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications. Diabetes Care 2003; 26 (4): 1246-50.
23. Komosinska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract. 2005; 68 (3): 207-16.
24. Tosukhowong P, Sangwatanaroj S, Jatuporn S, Prapunwattana P, Saengsiri A, Rattanapruks S, et al. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. Clin Hemorheol Microcirc 2003; 29 (3-4): 321-9.
25. Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Biochem 2005; 42 (Pt 2): 99-104.
26. Nojiri S, Daida H, Mokuno H, Iwama Y, Mae K, Ushiho F, Ueki T. Association of serum antioxidant capacity with coronary artery disease in midle-aged men. Jpn Heart J 2001; 42 (6): 677-90.